* Orgenesis Inc ORGS.OQ reported a quarterly adjusted loss
of 16
cents per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 4 cents per
share.
* Revenue fell 23.2% to $7.21 million from a year ago;
analysts
expected $6.30 million.
* Orgenesis Inc's reported EPS for the quarter was a loss
of 16
cents.
* The mean earnings estimate of analysts had risen by
about 78.9%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Orgenesis Inc shares had fallen by 40.3% this quarter and
lost 28.1% so far this year.
* The company reported a quarterly loss of $4.01 million.
* Wall Street's median 12-month price target for Orgenesis
Inc is
$9.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 23 at 07:42 p.m. All
figures in US dollars unless otherwise stated